Dialysis
GPOs: Teleflex inks dialysis deal with Premier
DaVita, Medtronic to study arrhythmia in dialysis patients
Medtronic: Hemodialysis patients at risk for arrhythmia
NxStage study highlights advantages of home hemodialysis
NxStage Medical’s single-needle home dialysis system comes to the U.S.
Massachusetts-based dialysis devices maker NxStage Medical (NSDQ:NXTM) won FDA clearance for its OneSite technology, cutting down on the number of needles dialysis patients must endure during therapy.
Baxter recalls dialysis solution over contamination concerns
Medtronic opens hemodialysis plant in China
FDA warns Baxter on HomeChoice dialysis system, infusion pump
NxStage launches dialysis patient outreach program
NxStage Medical (NSDQ:NXTM) launched a new patient outreach program called NxStage Plus One, through which it hopes to increase awareness of home hemodialysis with the NxStage System One.